SOCS2 and breast cancer: Moreover, according to Liu et al., when miR-3613-3p was downregulated in the CAFs exosomes, SOCS2 expression (a suppressor of cytokine signaling 2) was targeted and breast cancer cell metastasis was diminished, suggesting that miR-3613-3p functions as a potential therapeutic target [106].